低剂量胆固醇对心房移除后长期复发的影响
Mohammed Al-Sadawi1, Faisal Aslam2, Matthew D Henriques2
1Cardiovascular department, University of Michigan Hospital, Ann Arbor, MI, USA.
International journal of cardiology
|January 10, 2025
概括
在心房动 (AF) 废除后使用低剂量的胆固醇与长期AF复发的减少有关. 需要进一步的随机试验来证实菌素.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心房动 (AF) 切除是一种常见的程序,通常伴随着胆固醇来控制炎症并防止复发.
- 有限的长期数据存在于科尔奇辛在减少AF复发后移除后的有效性.
研究的目的:
- 调查低剂量胆固醇对AF切除后AF复发率的长期影响.
- 评估黄素作为辅助疗法的有效性,以评估AF切除结果.
主要方法:
- 对1568例AF消去 (2013-2021) 进行了回顾性分析,检查了胆固醇的使用 (每天0.3-0.6毫克,持续30天).
- 倾向性得分匹配 (1:1) 用于控制混变量.
- 卡普兰-梅尔分析评估了AF复发的时间,定义为AF检测>30秒后3个月的空白期.
主要成果:
- 胆固醇的使用 (在78%的患者中) 与AF复发的显著减少有关 (HR 0.78,p=0.022).
- 在倾向分数匹配的队列中 (每组275名患者),素使用仍然与较低的AF复发率相关 (HR 0.71,p=0.026).
- 平均随访时间为34个月,最低6个月.
结论:
- 低剂量胆固醇治疗似乎与AF消去后长期AF复发的减少有关.
- 建议进行随机的安慰剂对照试验,以验证这些发现,并确定抽取后的常规使用胆固醇.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
607
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
607
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
900
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
900
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
465
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
465


